The store will not work correctly when cookies are disabled.
N-(2-chlorophenyl)benzo[d]isoxazole-3-carboxamide
ID: ALA1078237
PubChem CID: 46882661
Max Phase: Preclinical
Molecular Formula: C14H9ClN2O2
Molecular Weight: 272.69
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ccccc1Cl)c1noc2ccccc12
Standard InChI: InChI=1S/C14H9ClN2O2/c15-10-6-2-3-7-11(10)16-14(18)13-9-5-1-4-8-12(9)19-17-13/h1-8H,(H,16,18)
Standard InChI Key: BRRQXQHULRURAR-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
6.8437 -8.0242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8425 -8.8514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5574 -9.2643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5556 -7.6115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2708 -8.0205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2757 -8.8469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0631 -9.0977 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.5450 -8.4263 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.0552 -7.7606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0723 -6.9377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7940 -6.5383 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.3655 -6.5123 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3805 -5.6875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1069 -5.2915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1222 -4.4675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4172 -4.0484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6907 -4.4451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6790 -5.2678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9584 -5.6694 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
9 5 1 0
4 1 1 0
9 10 1 0
5 6 1 0
10 11 2 0
10 12 1 0
2 3 1 0
12 13 1 0
3 6 2 0
13 14 2 0
1 2 2 0
14 15 1 0
5 4 2 0
15 16 2 0
6 7 1 0
16 17 1 0
7 8 1 0
17 18 2 0
18 13 1 0
8 9 2 0
18 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 272.69 | Molecular Weight (Monoisotopic): 272.0353 | AlogP: 3.73 | #Rotatable Bonds: 2 |
Polar Surface Area: 55.13 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.51 | CX Basic pKa: ┄ | CX LogP: 3.44 | CX LogD: 3.44 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.77 | Np Likeness Score: -1.86 |
References
1. Qiao L, Choi S, Case A, Gainer TG, Seyb K, Glicksman MA, Lo DC, Stein RL, Cuny GD.. (2009) Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors., 19 (21): [PMID:19783434] [10.1016/j.bmcl.2009.09.010] |
2. Xue Z, Li H, Xie W, Xu Y, Zhou L, Qu ZB.. (2022) Benzo[d]isoxazole Derivatives as Hypoxia-Inducible Factor (HIF)-1α Inhibitors., 13 (12.0): [PMID:36518694] [10.1021/acsmedchemlett.2c00308] |